| In vitro cell migration and invasion assays N Kramer, A Walzl, C Unger, M Rosner, G Krupitza, M Hengstschläger, ... Mutation Research/Reviews in Mutation Research 752 (1), 10-24, 2013 | 949 | 2013 |
| Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT–mTOR–S6K signaling and drug responses A Riedl, M Schlederer, K Pudelko, M Stadler, S Walter, D Unterleuthner, ... Journal of cell science 130 (1), 203-218, 2017 | 480 | 2017 |
| Modeling colon adenocarcinomas in vitro: A 3D co-culture system induces cancer-relevant pathways upon tumor cell and stromal fibroblast interaction H Dolznig, C Rupp, C Puri, C Haslinger, N Schweifer, E Wieser, ... The American journal of pathology 179 (1), 487-501, 2011 | 213 | 2011 |
| Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin H Dolznig, N Schweifer, C Puri, N Kraut, WJ Rettig, D Kerjaschki, ... Cancer immunity 5 (1), 2005 | 209 | 2005 |
| Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer D Unterleuthner, P Neuhold, K Schwarz, L Janker, B Neuditschko, ... Angiogenesis 23, 159-177, 2020 | 207 | 2020 |
| Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse D Kerjaschki, Z Bago-Horvath, M Rudas, V Sexl, C Schneckenleithner, ... The Journal of clinical investigation 121 (5), 2000-2012, 2011 | 199 | 2011 |
| Hepatic tumor–stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge F Van Zijl, M Mair, A Csiszar, D Schneller, G Zulehner, H Huber, R Eferl, ... Oncogene 28 (45), 4022-4033, 2009 | 195 | 2009 |
| Evidence for a size-sensing mechanism in animal cells H Dolznig, F Grebien, T Sauer, H Beug, EW Müllner Nature cell biology 6 (9), 899-905, 2004 | 181 | 2004 |
| STAT3 regulated ARF expression suppresses prostate cancer metastasis J Pencik, M Schlederer, W Gruber, C Unger, SM Walker, A Chalaris, ... Nature communications 6 (1), 7736, 2015 | 179 | 2015 |
| Apoptosis protection by the Epo target Bcl-XL allows factor-independent differentiation of primary erythroblasts H Dolznig, B Habermann, K Stangl, EM Deiner, R Moriggl, H Beug, ... Current Biology 12 (13), 1076-1085, 2002 | 174 | 2002 |
| Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2 F Grebien, MA Kerenyi, B Kovacic, T Kolbe, V Becker, H Dolznig, K Pfeffer, ... Blood, The Journal of the American Society of Hematology 111 (9), 4511-4522, 2008 | 166 | 2008 |
| Modeling human carcinomas: physiologically relevant 3D models to improve anti-cancer drug development C Unger, N Kramer, A Walzl, M Scherzer, M Hengstschlaeger, H Dolznig Advanced drug delivery reviews 79, 50-67, 2014 | 158 | 2014 |
| PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomas D Laimer, H Dolznig, K Kollmann, PW Vesely, M Schlederer, O Merkel, ... Nature medicine 18 (11), 1699-1704, 2012 | 143 | 2012 |
| IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor–stroma interaction C Rupp, M Scherzer, A Rudisch, C Unger, C Haslinger, N Schweifer, ... Oncogene 34 (7), 815-825, 2015 | 141 | 2015 |
| Leukemic transformation of normal murine erythroid progenitors: v-and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis M Von Lindern, EM Deiner, H Dolznig, M Parren-van Amelsvoort, ... Oncogene 20 (28), 3651-3664, 2001 | 129 | 2001 |
| FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts R Pereira, CT Quang, I Lesault, H Dolznig, H Beug, J Ghysdael Oncogene 18 (8), 1597-1608, 1999 | 128 | 1999 |
| Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression N Kramer, J Schmöllerl, C Unger, H Nivarthi, A Rudisch, D Unterleuthner, ... Oncogene 36 (39), 5460-5472, 2017 | 124 | 2017 |
| Directed differentiation and mass cultivation of pure erythroid progenitors from mouse embryonic stem cells S Carotta, S Pilat, A Mairhofer, U Schmidt, H Dolznig, P Steinlein, H Beug Blood 104 (6), 1873-1880, 2004 | 120 | 2004 |
| Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arrays H Dolznig, F Boulmé, K Stangl, EM Deiner, W Mikulits, H Beug, ... The FASEB Journal 15 (8), 1442-1444, 2001 | 120 | 2001 |
| Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments MJ Del Prete, R Vernal, H Dolznig, EW Müllner, JA Garcia-Sanz Rna 13 (3), 414-421, 2007 | 118 | 2007 |
